Article Information
History
- May 8, 2021.
Article Versions
- You are currently viewing Version 1 of this article (May 8, 2021 - 18:54).
- View Version 2, the most recent version of this article.
Copyright
The copyright holder for this preprint is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-ND 4.0 International license.
Author Information
- Elisha D.O. Roberson1,2,*,
- Rosana A. Mesa1,
- Gabrielle A. Morgan3,
- Li Cao1,
- Wilfredo Marin4 and
- Lauren M. Pachman3,4,5,*
- 1Department of Medicine, Division of Rheumatology, Washington University, St. Louis, MO, USA
- 2Department of Genetics, Washington University, St. Louis, MO, USA
- 3Division of Pediatric Rheumatology, Ann & Robert H. Lurie Children’s Hospital of Chicago, Chicago, Illinois, USA
- 4Cure JM Center of Excellence in Juvenile Myositis (JM) Research and Care, Stanley, Manne Children’s Research Institute, Chicago, Illinois, USA
- 5Northwestern University Feinberg School of Medicine, Chicago, Illinois, USA
- ↵*Corresponding authors: Lauren M. Pachman, M.D., Ann & Roberson H. Lurie Children’s Hospital of Chicago Box 50, Pediatric Rheumatology, 225 East Chicago Avenue Chicago, Illinois 60611, pachman{at}northwestern.edu, Elisha D.O. Roberson, Ph.D. Washington University in St. Louis 660 South Euclid Avenue Campus Box 8045, St. Louis, MO 63110, eroberson{at}wustl.edu
The authors have declared that no conflict of interest exists.
Posted May 08, 2021.
Transcriptomes of peripheral blood mononuclear cells from juvenile dermatomyositis patients show elevated inflammation even when clinically inactive
